Public limited company · Seraing · incorporated on 02/05/2014 · 25,0 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12,5 M € | +21.8% | 10,2 M € | +11.9% | 9,2 M € | +24.2% | 7,4 M € | +12.4% | 6,6 M € | +13.8% | 5,8 M € | +2.9% | 5,6 M € | +0.9% | 5,6 M € | +1.3% | 5,5 M € | +24.4% | 4,4 M € | +1081.8% | 373,0 k € | |
| Gross margin | 3,4 M € | +37.1% | 2,4 M € | +0.3% | 2,4 M € | -7.4% | 2,6 M € | +30.7% | 2,0 M € | +33.6% | 1,5 M € | +42.9% | 1,1 M € | +17.0% | 901,6 k € | +5.2% | 856,9 k € | +80.4% | 475,0 k € | +1275.9% | 34,5 k € | |
| EBITDA | 962,1 k € | +541.3% | 150,0 k € | -76.2% | 630,8 k € | -34.9% | 969,0 k € | +69.3% | 572,3 k € | +53.7% | 372,2 k € | +128.7% | 162,8 k € | +372.4% | -59,8 k € | -129.4% | 203,2 k € | +40.4% | 144,7 k € | +257.7% | -91,7 k € | |
| Operating profit | 268,2 k € | +156.3% | -476,0 k € | -3953.2% | 12,4 k € | -96.0% | 312,4 k € | +420.4% | -97,5 k € | +57.4% | -228,9 k € | +26.6% | -311,7 k € | +25.8% | -420,1 k € | -20375.5% | 2,1 k € | +104.1% | -50,6 k € | +58.7% | -122,3 k € | |
| Profit/loss | 129,1 k € | +120.8% | -619,1 k € | -10292.6% | -6,0 k € | -102.1% | 279,5 k € | +707.1% | -46,0 k € | +70.3% | -155,2 k € | +56.4% | -355,7 k € | -3.3% | -344,2 k € | -638.4% | 63,9 k € | +265.3% | -38,7 k € | +69.6% | -127,2 k € | |
| Equity | 3,6 M € | +3.7% | 3,4 M € | -11.4% | 3,9 M € | -0.2% | 3,9 M € | +7.7% | 3,6 M € | +32.4% | 2,7 M € | -7.9% | 3,0 M € | +98.6% | 1,5 M € | -22.2% | 1,9 M € | +5.0% | 1,8 M € | +304.0% | 452,3 k € | |
| Total assets | 8,0 M € | -5.1% | 8,4 M € | +34.3% | 6,3 M € | -12.6% | 7,2 M € | +17.9% | 6,1 M € | +10.2% | 5,5 M € | +0.3% | 5,5 M € | +11.6% | 4,9 M € | +13.7% | 4,3 M € | +13.5% | 3,8 M € | +275.7% | 1,0 M € | |
| Cash | 231,6 k € | -10.1% | 257,6 k € | -26.7% | 351,6 k € | -66.7% | 1,1 M € | +16.1% | 907,9 k € | +557.5% | 138,1 k € | +85.5% | 74,4 k € | +26.0% | 59,1 k € | -68.1% | 185,4 k € | -0.5% | 186,3 k € | -30.0% | 266,3 k € | |
| Debts | 3,9 M € | -14.1% | 4,6 M € | +121.1% | 2,1 M € | -26.7% | 2,8 M € | +19.7% | 2,4 M € | -15.7% | 2,8 M € | +10.0% | 2,5 M € | -26.0% | 3,4 M € | +41.9% | 2,4 M € | +21.3% | 2,0 M € | +253.3% | 564,5 k € | |
| Staff | 25 | 25,6 | 22,6 | 20,5 | 18,6 | 16,4 | 11,9 | 11,3 | 8,5 | 5,6 | 1,8 | |||||||||||
Public limited company profitable and well capitalised. Cash position declining (-10.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ELYSIA is a Public limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Seraing. It employs on average 25,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette